Avista Public Acquisition Corp. II
Status: Deal Closed
U=S+W/3
W=S@11.5
| IPO Proceeds, $M | $230.00M |
|---|---|
| IPO Date | Aug 10, 2021 |
| CEO | David Burgstahler |
| Left Lead | Credit Suisse |
| IPO Cash in Trust | 102.5% |
| SPAC Tenor | 18 months |
| IPO Sector | Healthcare |
| IPO Geography | Global |
| Target Company | OmniAb |
| Deal Announced | Mar 23, 2022 |
| Deal Size, $M | $884.00M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings | www.sec.gov |
| Approval Vote | Oct 24, 2022 |
| Amendment Vote | TBD |
| Closing Date | Nov 1, 2022 |
Formerly AHPA
OABI
OABIW
| Price | $3.90 |
|---|---|
| Last closing price | $3.84 |
| H/L, today | $3.64 / $3.91 |
| H/L, 52-week | $1.91 / $5.98 |
| Volume, today | 622,097 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Avista Public Acquisition Corp. II:
- Structure and cap table
- 11 directors & officers
- 27 filings and events
- 1 underwriters
- 9 deal advisors
- 1 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Thompson Dean | 63 | Executive Chairman and Director |
| David Burgstahler | 52 | President, Chief Executive Officer and Director |
| Sriram Venkataraman | 49 | Executive Vice President |
| Robert Girardi | 39 | Executive Vice President |
| Amanda Heravi | 46 | Investor Relations Officer |
| John Cafasso | 48 | Chief Financial Officer |
| Benjamin Silbert | 50 | General Counsel |
| William E. Klitgaard | 68 | Director |
| Lâle White | 66 | Director |
| Wendel Barr | 59 | Director |
| Charles Harwood | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| Credit Suisse | BR | 20,000,000 | units |
| 20,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee |
3.50 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.